Share

April 12, 2016; 86 (15) Article

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy

Erin E. Sundermann, Anat Biegon, Leah H. Rubin, Richard B. Lipton, Wenzhu Mowrey, Susan Landau, Pauline M. Maki, For the Alzheimer's Disease Neuroimaging Initiative
First published March 16, 2016, DOI: https://doi.org/10.1212/WNL.0000000000002570
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
505

Share

Article Information

vol. 86 no. 15 1368-1376
DOI: 
https://doi.org/10.1212/WNL.0000000000002570
PubMed: 
26984945
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 4, 2015
  • Accepted in final form October 26, 2015
  • First Published March 16, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Erin E. Sundermann, PhD,
    2. Anat Biegon, PhD,
    3. Leah H. Rubin, PhD,
    4. Richard B. Lipton, MD,
    5. Wenzhu Mowrey, PhD,
    6. Susan Landau, PhD,
    7. Pauline M. Maki, PhD;
    8. For the Alzheimer's Disease Neuroimaging Initiative
  1. Erin E. Sundermann, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel award from the Alzheimer's Association International Conference (AAIC) to present at the AAIC 2015 annual meeting

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Fees for consulting on neurocognitive test administration from the Women's Interagency HIV Study (WIHS)

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. My time from 3/2013 to 3/16 is supported by funding for the Einstein Aging Study: National Institute on Aging Grant AG003949, AG026728, TL1RR000087, T32-GM007288, the Leonard and Sylvia Marx Foundation, and the Czap Foundation.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The Leonard and Sylvia Marx Foundation and the Czap Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Anat Biegon, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1. Future Neurology, editorial advisory board member 2012- The Open Neuroimaging Journal, editorial advisory board member 2012- The Scientific World Journal, editorial advisory board member 2013- World Journal of Radiology, editorial advisory board member 2014- Concussion, editorial advisory board member 2015-

    Patents:

    1. 1. Biegon, A. In Vivo imaging agent and method for diagnosis of psychiatric disorders. US patent application no. 07/614 434 , filed 16/11/90, in allowance 2. Mathis, C., Biegon, A., Enas, J. and Taylor, S. Substituted 6- nitroquipazines, methods of preparation and methods of use. US patent application no. 07/994 825, filed 22/12/92, In allowance 3. Kloog, Y. Mechoulam, R. Sokolovsky, M. and Biegon, A. NMDA blocking pharmaceutical compositions. US patent application filed Feb. 1994 in allowance 4. Mechoulam R., Breuer A. and Biegon A. Novel phenyl pinene derivatives. US patent application filed Feb. 1994 in allowance 5. Biegon A., Brewster M. Permanently charged derivatives of steroids and steroid Antagonists. US patent application filed April 1994 in allowance 6. Kim S-W, Biegon A., Fowler J. Radio-methyl vorozole and methods for making and using the same. US patent application filed 2009 in allowance.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. NIH 1R01CA195506-01 (Cohen&Biegon MPI) 5/19/2015-5/18/2017 2. NIH 1R21CA179425-01 (Cohen and Biegon, co-PIs) 9/19/2014-9/18/2016 3. NIH 1R21DA032858 (MPI: Hildebrandt, Biegon) 2/1/12- 1/31/16

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Leah H. Rubin, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIMH: 1K01MH098798-01

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Richard B. Lipton, MD,
    5. Scientific Advisory Boards:

    1. Allergan, e-Neura, Merck

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Serve as consultant, advisory board member or received honoraria from: Alder, Allergan, American Headache Society, Arteaus, Autonomic Technologies, Boston Scientific, Bristol Myers Squibb, CoLucid, Dr. Reddys, Electrocore, Eli Lilly, eNeura, Informa, Merck, Novartis, Pfizer, Teva, Vedanta

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Oxford University Press; Baxter Publishing

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Serve as consultant, advisory board member or received honoraria from: Alder, Allergan, American Headache Society, Arteaus, Autonomic Technologies, Boston Scientific, Bristol Myers Squibb, CoLucid, Dr. Reddys, Electrocore, Eli Lilly, eNeura, Informa, Merck, Novartis, Pfizer, Teva, Vedanta

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Bristol Myers Squibb Early Detection of Alzheimer's Disease June 2010 - present Vedanta Research Migraine epidemiology and Progression June 2010 - present Boston Scientific Occipital Nerve Stimulation in Migraine March 2013 - present ElectroCore Vagal Nerve Stimulation for Migraine and Cluster May 2013 Novartis Sleep and Migraine September 2012 - present Allergan Botox in Migraine April 2012 - present Allergan Chronic Migraine Epidemiology and Outcome Study January 2012 - present

    Research Support, Government Entities:

    1. P01 AG03949 4/1/11-3/31/16 Einstein Aging Study Role: Principle Investigator 1KL2RR025749 07/01/09-06/30/13 Clinical and Translational Science Award (CTSA) Research Career Development Award Role: Primary Mentor R01AG022374 8/1/10-7/31/15 Biomarkers in Early Alzheimer?s Disease Role: Investigator R01AG034119 8/1/10-7/31/15 Two Preclinical Latent Scores to Predict Occurrence of DAT Role: PI, Einstein Site R01AG012101 9/15/10-7/31/15 MRI Progression Markers of Cognitive Decline in the Elderly Role: PI, Einstein Site 1R01AG039409-01 Stress, Unconstructive Repetitive Thought & Cognitive Aging 4/1/11-3/31/16 Role: PI, Einstein Site 1R01AG038651-01A1 Role of impaired cognitive states & risk factors in conversion to mixed dementias 9/1/11-8/31/16 Role: PI, Einstein Site 1U10NS077308- 01 9/30/11-8/31/18 Einstein Center for Excellence for Clinical Trials in Neuroscience Role: PI NIH 4/1/12-3/31/17 Behavioral Weight Loss as a Treatment for Migraine in Obese Women Role: Investigator NIH 1R01AG042595 - 01A1 Stress, cognition, repetitive unconstructive thoughts and inflammatory markers Role: Investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. S & L Marx Foundation Alzheimer's Research

    Stock/Stock Options/Board of Directors Compensation:

    1. eNeura Pharma

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. Oxford University Press; Baxter Publishing

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Wenzhu Mowrey, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH R21NS078333, co-investigator, 9/1/12−8/31/14 (2) Department of Defense, titled “Identifying new therapies for infantile spasms”, co-investigator, 9/30/13−9/29/16

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Citizens United for Research in Epilepsy (CURE) (2) Rett Syndrome Research Trust

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Susan Landau, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Janssen/J&J Research & Dev, speaking honoraria and travel fees (2) Mount Sinai Medical Center, travel fees

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consulting work for Biogen Idec, Synarc

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) National Institutes of Health Grant U01 AG024904 Alzheimer's Disease Neuroimaging Initiative (ADNI) (2) W81XWH-12-2-0012 DOD ADNI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Pauline M. Maki, PhD;
    8. Scientific Advisory Boards:

    1. (1) Pfizer (2) Abbott (3) Noven

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Abbott, travel compensation and speaking honorarium (2) Noven, travel compensation and speaking honorarium (3) Pfizer, travel compensation and consulting fee (4) North American Menopause Society, travel compensation (4) Creative and Novel Ideas in HIV Research, International AIDS Society and NIH, travel compensation

    Editorial Boards:

    1. Editorial Board Member, Menopause, 2009-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Pfizer , Abbott, Noven

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Member of the Board of Trustees of the North American Menopause Society

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIMH 1 R01 MH083782-01A1, Principal Investigator, 2009-2014 (2) NIAID 2U01 AI034993-15, Investigator, 2009- 2018 (3) AI 1 P30AI082151-01, Investigator, 2009-2014 (4) NICHD 1K12HD055892-01, Program Director, 2010-2016 (5) NIMH 1R21 MH099978 01A1, Co-Investigator, 2013-2015 (6) NIDA 5 R01 DA012828-12, Co-Investigator, 2013-2017

    Research Support, Academic Entities:

    1. (1) University of Illinois at Chicago, Chancellor's Discovery Fund, 2013-2015

    Research Support, Foundations and Societies:

    1. (1) International AIDS Society and the NIH Creative and Novel Ideas in HIV Research

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. For the Alzheimer's Disease Neuroimaging Initiative
    1. From the Einstein Aging Study and the Department of Neurology (E.E.S., R.B.L.) and the Department of Epidemiology and Population Health (W.M.), Albert Einstein College of Medicine, Bronx; Department of Neurology (A.B.), State University of New York, Stony Brook; Department of Psychiatry (L.H.R., P.M.M.), University of Illinois at Chicago; and Helen Wills Neuroscience Institute (S.L.), University of California, Berkeley.
    1. Correspondence to Dr. Sundermann: erin.sundermann{at}einstein.yu.edu
    View Full Text

    Article usage

    Article usage: March 2016 to February 2023

    AbstractFullPdfSource
    Mar 20161153034Highwire
    Apr 201624752854Highwire
    May 20164651518Highwire
    Jun 2016241108Highwire
    Jul 201614559Highwire
    Aug 201616987Highwire
    Sep 201612604Highwire
    Oct 2016201107Highwire
    Nov 201613511Highwire
    Dec 201610934Highwire
    Jan 201711656Highwire
    Feb 20179453Highwire
    Mar 20177622Highwire
    Apr 20178500Highwire
    Apr 2017587pmc
    May 20177731Highwire
    May 2017131718pmc
    Jun 20175821Highwire
    Jun 2017056pmc
    Jul 20175710Highwire
    Jul 201751113pmc
    Aug 20178010Highwire
    Aug 201771314pmc
    Sep 20174101Highwire
    Sep 201721010pmc
    Oct 20177111Highwire
    Oct 201792021pmc
    Nov 20174544Highwire
    Nov 2017102319pmc
    Dec 20172711Highwire
    Jan 20183700Highwire
    Feb 20183600Highwire
    Mar 20183501Highwire
    Apr 20183101Highwire
    Apr 201841717pmc
    May 20184511Highwire
    Jun 20183701Highwire
    Jun 201841921pmc
    Jul 20182811Highwire
    Aug 20182930Highwire
    Aug 201821413pmc
    Sep 20183100Highwire
    Oct 20187211Highwire
    Nov 20184900Highwire
    Dec 20185122Highwire
    Jan 20194221Highwire
    Feb 20193100Highwire
    Mar 20193400Highwire
    Apr 20192931Highwire
    May 20193510Highwire
    Jun 20192210Highwire
    Jul 20194512Highwire
    Aug 20192500Highwire
    Sep 20193111Highwire
    Oct 20193421Highwire
    Nov 20193012Highwire
    Dec 20192422Highwire
    Jan 20203812Highwire
    Feb 20204730Highwire
    Mar 20203320Highwire
    Apr 20203623Highwire
    May 20206500Highwire
    Jun 20203124Highwire
    Jul 20203010Highwire
    Aug 20202721Highwire
    Sep 20203711Highwire
    Oct 20204132Highwire
    Nov 20208253Highwire
    Dec 20204640Highwire
    Jan 20212100Highwire
    Feb 20213801Highwire
    Mar 20215020Highwire
    Apr 20214701Highwire
    May 20214120Highwire
    Jun 20214412Highwire
    Jul 20216821Highwire
    Aug 20215600Highwire
    Sep 20215801Highwire
    Oct 20215420Highwire
    Nov 20216001Highwire
    Dec 20217732Highwire
    Jan 20225900Highwire
    Feb 20226011Highwire
    Mar 202210632Highwire
    Apr 202211418Highwire
    May 202270457105Highwire
    Jun 20227221Highwire
    Jul 20228401Highwire
    Aug 202211120Highwire
    Sep 20226822Highwire
    Oct 20229170Highwire
    Nov 20226612Highwire
    Dec 20228711Highwire
    Jan 2023162513Highwire
    Feb 20238911Highwire

    Cited By...

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Related Articles

    Topics Discussed

    Alert Me

    Recommended articles